{"id":"W2946175247","doi":"10.1016/j.cgh.2019.05.013","title":"Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases","year":2019,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Toronto Liver Centre; University of Alberta","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Deutsche Forschungsgemeinschaft; University of Birmingham; National Institute for Health and Care Research; University Hospitals Birmingham NHS Foundation Trust; Wellcome Trust","keywords":"Vedolizumab; Medicine; Primary sclerosing cholangitis; Internal medicine; Gastroenterology; Liver transplantation; Cohort; Inflammatory bowel disease; Ulcerative colitis; Clinical endpoint; Bilirubin; Alkaline phosphatase; Transplantation; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000901585,0.0002785207,0.000835929,0.0003652335,0.0002882594,0.0003969054,0.0001367132,0.0003135563,0.0009458911],"category_scores_gemma":[0.00211738,0.0001309846,0.0006355091,0.0004854045,0.0002018673,0.0002639254,0.0002382644,0.0005099263,0.0001194262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003587067,"about_ca_system_score_gemma":0.0003257748,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001103548,"about_ca_topic_score_gemma":0.002909819,"domain_scores_codex":[0.9993836,0.0002555385,0.00007666149,0.00009397152,0.0001103298,0.00007996706],"domain_scores_gemma":[0.9987038,0.0004113067,0.0005104865,0.00003889125,0.00009268511,0.0002427143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01067226,0.0005553075,0.9437137,0.0002562822,0.0006591893,0.0005304813,0.0001215783,0.0002646051,0.002183247,0.00003644264,0.0005946154,0.04041228],"study_design_scores_gemma":[0.0005083598,0.003077863,0.9937668,0.00003903183,0.0003127653,0.0009871989,0.00007706848,0.0002389407,0.0001904366,0.00003781443,0.0007567236,0.000006961783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920672,0.006097248,0.00005603174,0.0002094889,0.00002385215,0.0000246231,0.000160819,0.000007489111,0.001353192],"genre_scores_gemma":[0.9986516,0.0007163333,0.0001102787,0.0001483656,0.00004670975,0.00001745451,0.0002148665,0.000001000398,0.00009360746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001103548,"threshold_uncertainty_score":0.004768074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00619690842481883,"score_gpt":0.2391362441734501,"score_spread":0.2329393357486313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}